Journals / Türk Oftalmoloji Dergisi / 2010 / Cilt: 40 - Sayı: 2

The levels of VEGF and IL-8 in vitreous samples from patients with proliferative vitreoretinopathy due to rhegmatogenous retinal detachment

Regmatojen retina dekolmanına bağlı gelişen proliferatif vitreoretinopatide vitreus sıvısında VEGF ve IL-8 seviyeleri

Pages
57–61
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: The vitreous concentrations of VEGF were significantly elevated in the samples from patients with retinal detachment (872.2±312.2 pg/ml [95.55-1991.38]), when compared with the samples from control patients (21.9±32.5 pg/ml [0.09-36.23] (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To determine the intravitreal IL-8, TNF-a and VEGF levels in patients with proliferative vitreoretinopathy (PVR) due to rhegmatogenous retinal detachment (RD) and to compare them with those in a control group.
📊
Key Findings & Data:Material and Method: Vitreous samples were collected from 27 eyes of 27 patients who underwent vitrectomy procedure for PVR due to RD and from 20 eyes of 20 patients, the control group, with macular hole during pars plana vitrectomy.
💡
Conclusion & Impact:Results: The vitreous concentrations of VEGF were significantly elevated in the samples from patients with retinal detachment (872.2±312.2 pg/ml [95.55-1991.38]), when compared with the samples from control patients (21.9±32.5 pg/ml [0.09-36.23] (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To determine the intravitreal IL-8, TNF-a and VEGF levels in patients with proliferative vitreoretinopathy (PVR) due to rhegmatogenous retinal detachment (RD) and to compare them with those in a control group. Material and Method: Vitreous samples were collected from 27 eyes of 27 patients who underwent vitrectomy procedure for PVR due to RD and from 20 eyes of 20 patients, the control group, with macular hole during pars plana vitrectomy. All PVR patients were stage A and stage B PVR (according to the criteria of the Retina Society Terminology Committee, 1983). Before intraocular infusion, the vitreous core was cut and 0.5 cc was aspirated via the pars plana under fluid-air exchange, and collected undiluted. The vitreous samples were immediately frozen at -70°C until assayed. Enzyme-linked immunosorbent assay of the samples was performed using human VEGF assay kit and human IL-8 assay kit obeying the manufacturer’s instructions. Results: The vitreous concentrations of VEGF were significantly elevated in the samples from patients with retinal detachment (872.2±312.2 pg/ml [95.55-1991.38]), when compared with the samples from control patients (21.9±32.5 pg/ml [0.09-36.23] (p

Özet

Amaç: Bu çalışmada amaçlanan, RD’a bağlı gelişen PVR olgularının vitreus sıvısından alınan örneklerde IL-8 ve VEGF seviyelerini çalışma grubu ile karşılaştırmaktır. Gereç ve Yöntem: Operasyon kararı verilen PVR’i olan 27 RD hastasının 27 gözü ve kontrol grubu olarak da 20 makula deliği olgusu kontrol grubu kapsamına alınmıştır. RD hastalarının tamamı evre A ve evre B (Retina Society Terminology Committee, 1983 kriterlerine göre) PVR gelişmiş RD arasından seçilmiştir. Vitreus örnekleri pars plana vitrektominin başlangıcında göz içi infüzyon açılmadan önce vitrektör ile dilüe edilmeden 0,5 cc aspire edilmiştir. Aspire edilen örnekler hemen steril epandorflara konulmuştur. Örnekler en kısa zamanda güneş ışığından korunarak -70 oC deki derin dondurucuya aktarılmıştır. Alınan vitreus örneklerinde IL-8 ve VEGF miktar analizi ELISA (Enzyme-linked immunosorbent assay) yöntemi ile ölçüldü. Sonuçlar IL-8 ve VEGF için pg/ml cinsinden hesaplandı. Sonuçlar: PVR grubundan vitrektomi sırasında elde edilen vitreus örneklerinde VEGF seviyesi (872,2±312,2 pg/ml [95,55-1991,38]) kontrol grubundan elde edilen vitreus örneklerindeki VEGF seviyesine (21,9±32,5 pg/ml [0,09-36,23] göre anlamlı olarak yüksek bulundu (p

🔖

Cite This Article

GÖRMÜŞ, U., ŞENGÜL, A., RASİER, R., BAHÇECİOĞLU, H., ÖNCEL, M., ARTUNAY, Ö., YÜZBAŞIOĞLU, E. (2022). The levels of VEGF and IL-8 in vitreous samples from patients with proliferative vitreoretinopathy due to rhegmatogenous retinal detachment. Türk Oftalmoloji Dergisi, Cilt: 40 - Sayı: 2, 57–61. https://ajindex.com/articles/638452

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Kanski JJ. Retinal Detachment. Clinical Ophthalmology. 3rd ed. Butterworth- Heinemann International Editions. 1994; p. 312-41
  2. Marmor MF: Structure, function and disease of the retinal pigment epithelium. in Marmor MF. Wolfensberger TJ: The retinal pigment epithelium. Oxford University Press, New York, Oxford.1998; p. 3-9
  3. Glaser BM, Lemor M: Pathobiology of proliferative vitreoretinopathy, in Ryan SJ (ed): Retina. 2nd ed. St Louis, CV Mosby, 1994, pp. 2249-63
  4. Miller B, Miller H, Patterson R, Ryan SJ: Retinal wound healing. Cellular activity at the vitreoretinal interface. Arch Ophthalmol. 1986;104:281-5
  5. Peyman GA, Shulman JA. Vitreous Substitutes. East Norwalk, Appleton and Lange, 1995
  6. Scott JD. Pathogenesis of PVR with analysis of events leading to recurrent retinal detachment, in Heimann K, Wiedemann P (eds). Proliferative Vitreoretinopathy. Heidelberg, Kaden. 1989; pp. 150-3
  7. Weller M, Wiedemann P, Heimann K. Proliferative vitreoretinopathy. Is it anything more than wound healing at the wrong place? Int Ophthalmol. 1990;14:105-17
  8. Wiedemann P, Weller M. The pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol. 1988;189:3-15
  9. Ryan SJ. The pathophysiology of proliferative vitreoretinopathy and its management. Am J Ophthalmol. 1985;100:188-93
  10. Girard P, Mimoun G. Kurpouzas I. Montefiore G. Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina. 199;14:417-24
  11. Aguirreberia A. Saornil MA, Giraldo A, Pastor JG. Incidencia de la vitreorretinopatia proliferante (VRP) en el desprendimiento de retina regmatogeno. Arch Soc Esp Oftalmol. 1986;51:229-34
  12. Cowley M, Conway BP, Campochiaro PA, Kaiser D, Gaskin H. Clinical risk factors for proliferative vitreoretinopathy. Arch Ophthalmol. 1989;107:1147-51
  13. Bonnet M: Clinical findings associated with the development of postoperative PVR in primary rhegmatogenous retinal detachment, in Heimann K. Wiedemann P (eds): Proliferative Vitreoretinopathy. Heidelberg, Kaden. 1989;8-20
  14. Bonnet M. Clinical factors predisposing to massive proliferative vitreoretinopathy in rhegmatogenous retinal detachment. Ophthalmologica (Basel). 1984;188;l48-52
  15. Bonnet M, Guenoun S. Surgical risk factors for severe postoperative proliferative vitreoretinopathy (PVR) in retinal detachment with grade B PVR. Graefes Arch Clin Exp Ophthalmol. 1995;233:789-91
  16. Garcia-Layana A, Hernando MT, Manzanas L, Pastor JC. Tratamiento profilactico